Germantown, MD, United States of America

Damien Yves Duveau

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Damien Yves Duveau. Retrieved from https://idiyas.com/inventor/damien-yves-duveau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Damien Yves Duveau: Innovator in Health Sciences

Introduction

Damien Yves Duveau is a notable inventor based in Germantown, MD (US). He has made significant contributions to the field of health sciences, particularly through his innovative research and patents.

Latest Patents

Damien holds a patent for "O-GLCNAC Transferase Inhibitors and Uses Thereof." This patent reflects his commitment to advancing medical science and improving health outcomes.

Career Highlights

He works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His role in this esteemed organization underscores his dedication to public health and innovation.

Collaborations

Damien has collaborated with esteemed colleagues, including Suzanne Walker Kahne and Sara Evelyn Schwanger Martin. These partnerships highlight the collaborative nature of scientific research and innovation.

Conclusion

Damien Yves Duveau is a prominent figure in the realm of health sciences, with a focus on innovative solutions that can lead to significant advancements in medical treatments. His work continues to inspire and contribute to the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…